Population Density Analysis of Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction in

Kyohei Yamaji1, Shun Kohsaka2, Taku Inohara2,3

  • 1Division of Cardiology Kokura Memorial Hospital Kitakyushu Japan.

Insights

Geographic disparities in ST-segment-elevation myocardial infarction treatment exist, with higher population density areas showing lower in-hospital mortality. More operators per institution may explain these improved outcomes for ST-elevation myocardial infarction patients.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • ST-segment-elevation myocardial infarction (STEMI) treatment has advanced, but geographic disparities in evidence-based therapy application persist.
  • Limited data exists on how population density influences the delivery and outcomes of STEMI care.

Purpose of the Study:

  • To investigate geographic disparities in in-hospital mortality among STEMI patients undergoing percutaneous coronary intervention (PCI).
  • To explore the association between population density and PCI outcomes, including door-to-balloon time and mortality.

Main Methods:

  • Analysis of the Japanese Percutaneous Coronary Intervention (J-PCI) registry data from 2014-2018, including 209,521 STEMI patients from 1126 institutions.
  • Patients were stratified into tertiles based on the population density (PD) of their PCI institution's location.
  • Statistical models were used to assess the correlation between PD, door-to-balloon time, number of operators, and in-hospital mortality, adjusting for baseline characteristics.

Main Results:

  • No significant correlation was found between population density and door-to-balloon time.
  • Patients in lower population density areas had higher crude and adjusted in-hospital mortality rates compared to those in high PD areas.
  • Higher population density areas had more operators per institution, which was inversely associated with in-hospital mortality.

Conclusions:

  • Geographic inequality in in-hospital mortality for STEMI patients undergoing PCI was observed.
  • The number of operators per institution, not traditional quality indicators like door-to-balloon time, may be a key factor explaining these observed mortality differences.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
514
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
123
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
142
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
277
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
513
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
748